-
-
-
-
-
-
-
UBS Upgrades Cytokinetics (CYTK) to Buy
-
-
-
-
-
-
-
Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar
-
-
-
-
-
-
-
Cytokinetics to Announce Third Quarter Results on November 5, 2025
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Cytokinetics (CYTK)
-
-
-
-
-
-
-
JMP Securities Reiterates Market Outperform Rating on Cytokinetics (CYTK)
-
-
-
-
-
-
-
Midday movers: Nvidia, Dell rise; Live Nation, Boeing fall
-
1,233,794 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


